Drug Discovery, Development and Delivery

Special Issues

Following special issues within this section are currently open for submissions:

• Drugs Targeting the Disease Progression, Cognitive Impairment, Anxiety and Other Co-morbidities in Epilepsy: From Bench to Bedside (Deadline: 31 December 2024)
• Advanced Research in Drug Delivery across the Blood–Brain Barrier (BBB) (Deadline: 31 December 2024)
• Natural and Synthetic Molecules with Anticancer Activity: Pharmacological Basis and Mechanistic Insight (Deadline: 31 December 2024)
• Advancing Pharmacogenetics in Pre-clinical Research: Unveiling New Avenues for Precision Medicine (Deadline: 31 December 2024)
• Applications and Developments of Metal-Based Drugs (Deadline: 31 December 2024)
• Cholinergic System Neurodegeneration: Novel Pharmacotherapy (Deadline: 31 December 2024)
• Innovative Approaches in Drug Design: The Pathway from Molecular Mechanisms to New Therapeutic Interventions (Deadline: 20 January 2025)
• State-of-the-Art Surfactant in Biomedical Application: A Commemorative Issue in Honor of Prof. Tetsuro Fujiwara (Deadline: 31 January 2025)
• Integrative Genomic Analysis, Big Data Processing and Programming, and Pharmaco-Informatics in Biomedicine (Deadline: 31 January 2025)
• Natural Product for the Interventions of Chronic Diseases: From Source to Therapy (Deadline: 31 January 2025)
• Recent Advances in the Discovery of Novel Drugs on Natural Molecules, Second Edition (Deadline: 31 January 2025)
• Recent Advances in Drug Synthesis and Drug Discovery (Deadline: 28 February 2025)
• Innovative Approaches in Drug Discovery (Deadline: 28 February 2025)
• Feature Reviews in Target Identification and Drug Discovery (Deadline: 28 February 2025)
• New Horizons in Enzyme Inhibitor Discovery: Targets, Design and Evaluation (Deadline: 28 February 2025)
• Exploitation and Development of “Synthetic Lethality” Strategy for Cancer Therapy (Deadline: 28 February 2025)
• Bioactive Peptides and Derivatives as Therapeutic Agents: Potential Applications in Disease Treatment (Deadline: 28 February 2025)
• State-of-the-Art Drug Discovery and Development in Poland (2nd Edition) (Deadline: 15 March 2025)
• Compounds from Natural Products as Sources for Drug Discovery (Deadline: 31 March 2025)
• Exploring Protein-Ligand Interaction: Key Insights for Drug Discovery (Deadline: 31 March 2025)
• Emerging Research and Applications in Target and Drug Discovery Field (Deadline: 30 April 2025)
• The Neuropharmacology of Cannabinoids: Developments in Medicine (Deadline: 30 April 2025)
• Molecular Research in Substance Abuse: Toxicity, Neurotoxicity and Neuropathological Findings (Deadline: 30 April 2025)
• Role of Natural Product in Cardiovascular Disease—2nd Edition (Deadline: 30 April 2025)
• Advances in Novel Drug Discovery, Synthesis, and Evaluation (Deadline: 30 April 2025)
• New Advances in Cardiovascular Drugs: In Memory of Professor Akira Endo (Deadline: 30 April 2025)
• Poly-Pharmacological Effects and Mechanisms of Phytochemicals (Deadline: 30 April 2025)
• Feature Reviews in Drug Design and Drug Development (Deadline: 30 April 2025)
• Medicinal Chemistry in Drug Design and Discovery, 2nd Edition (Deadline: 31 May 2025)
• Application of New Technologies in Drug Delivery (Deadline: 31 May 2025)
• Recent Advances in Targeted Drug Delivery Systems (Deadline: 31 May 2025)
• Histone Deacetylase and Its Inhibitors: Drug Discovery, Molecular Mechanism, and Clinical Implications (Deadline: 31 May 2025)
• Peptides and Amino Acids in Drug Development: Here and Now (Deadline: 6 June 2025)
• Antioxidant and Antimicrobial Potencies of Biomolecule (Deadline: 11 June 2025)
• Progress in Cardiovascular Pharmacology (Deadline: 31 August 2025)

Topical Collection

Following topical collection within this section is currently open for submissions:

• Feature Papers in Drug Discovery